ORIGINAL RESEARCH
Accepted on 02 Oct 2025
Preclinical Biodistribution and Toxicology Assessment of an AAV5-Based Subretinal Modifier Gene Therapy for Retinitis Pigmentosa
doi 10.3389/fmed.2025.1679619
- Frontiers in Medicine
- Gene and Cell Therapy
- Research Topics
- Next-Generation Gene and Cell Therapies: Targeting Diseases at Their Origin
Next-Generation Gene and Cell Therapies: Targeting Diseases at Their Origin
2,624
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.